Manish Sahni, MDa board-certified internist with a proven track record in managing complex metabolic conditions including obesity and type 2 diabetespatients receive individualized care tailored to their unique health needs and goals
therefore, actual doses administered may be unstable, so that the bacteria are not completely cleared from the treated mice, and levels of clearance vary between individuals
Some saw even more, depending on lifestyle factors and how early the medication was introduced
The reality is more nuanced: thyroid disease requires informed decision-making and close monitoring, but it doesn't universally prohibit GLP-1 therapy
Goyal S, Kumar S, Bijjem KV, Singh M: Role of glucagon-like peptide- 1 in vascular endothelial dysfunction